Olena Mitchenko

ORCID: 0000-0001-6692-6883
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lipoproteins and Cardiovascular Health
  • Cardiovascular Disease and Adiposity
  • Cancer, Lipids, and Metabolism
  • Diet and metabolism studies
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Diet, Metabolism, and Disease
  • Nutrition, Genetics, and Disease
  • Health Systems, Economic Evaluations, Quality of Life
  • Human Health and Disease
  • Hormonal Regulation and Hypertension
  • Lipid metabolism and disorders
  • Microbial Metabolism and Applications
  • Nutritional Studies and Diet
  • Menopause: Health Impacts and Treatments
  • Atherosclerosis and Cardiovascular Diseases
  • Thyroid Disorders and Treatments
  • Regulation of Appetite and Obesity
  • Consumer Attitudes and Food Labeling
  • Healthcare Systems and Public Health
  • Liver Disease Diagnosis and Treatment
  • Cardiac Imaging and Diagnostics
  • Fatty Acid Research and Health
  • Renal function and acid-base balance
  • Estrogen and related hormone effects
  • Adipose Tissue and Metabolism

National Scientific Center "M.D. Strazhesko Institute of Cardiology"
2012-2022

National Academy of Medical Sciences of Ukraine
2015-2022

European Atherosclerosis Society
2021

Ukrainian Academy of Banking of the National Bank of Ukraine
2019

Institute of Urology of the National Academy of Medical Sciences of Ukraine
2004

1.1. Cardiovascular disease and dyslipidemia: prevalence global economic impact Cardiovascular diseases (CVDs) are the leading cause of mortality worldwide, reaching 31% deaths in 2012 [1]. In particular, atherosclerosis ischemic heart (IHD) main causes premature death Europe responsible for 42% women 38% men under 75 years old [2]. The impact CVD is estimated to have been US $906 billion 2015 expected rise by 22% 2030 [3]. also represent major disability developed countries. It has that...

10.5114/aoms.2017.69326 article EN cc-by-nc-sa Archives of Medical Science 2017-01-01
Antonio J. Vallejo‐Vaz C. Stevens Alexander R.M. Lyons Kanika Dharmayat Tomáš Freiberger and 95 more G. Kees Hovingh Pedro Mata Frederick J. Raal Raúl D. Santos Handrean Soran Gerald F. Watts Marianne Abifadel Carlos A. Aguilar-Salinas Khalid F. AlHabib Mutaz Al-Khnifsawi Wael Almahmeed Fahad Alnouri Rodrigo Alonso Khalid Al‐Rasadi Ahmad Al‐Sarraf Nasreen Al-Sayed Francisco Araújo Tester F. Ashavaid Maciej Banach Sophie Béliard Marianne Benn Christoph J. Binder Martin P. Bogsrud Mafalda Bourbon Krzysztof Chlebus Pablo Corral Kairat Davletov Olivier Descamps Ronen Durst М. В. Ежов Dan Gaiţă Jacques Genest Urh Grošelj Mariko Harada‐Shiba Kirsten B. Holven Meral Kayıkçıoğlu Weerapan Khovidhunkit Katarina Lalić Gustavs Latkovskis Ulrich Laufs Evangelos Liberopoulos Marcos M. Lima-Martínez Jie Lin Vincent Maher Adéle Marais Winfried März Erkin М Мirrakhimov André R. Miserez Olena Mitchenko Hapizah Nawawi Børge G. Nordestgaard Andrie G. Panayiotou György Paragh Žaneta Petrulionienė Belma Pojskić Arman Postadzhiyan Katarı́na Rašlová Ashraf Reda Željko Reiner Fouzia Sadiq Wilson E. Sadoh Heribert Schunkert Aleksandr B. Shek Mario Stoll Erik S.G. Stroes Ta‐Chen Su Subramaniam Tavintharan Andrey V. Susekov Myra Tilney Brian Tomlinson Thanh Huong Truong Alexandros D. Tselepis Anne Tybjærg‐Hansen Alejandra Cárdenas Margus Viigimaa Luya Wang Shizuya Yamashita John J.P. Kastelein Éric Bruckert Branislav Vohnout Laura Schreier Jing Pang Christoph Ebenbichler Hans Dieplinger Reinhold Innerhofer Yvonne Winhofer-Stöckl Susanne Greber‐Platzer Konstantin A. Krychtiuk Walter S. Speidl Hermann Toplak Kurt Widhalm Thomas M. Stulnig Kurt Huber Florian Höllerl Gersina Rega‐Kaun

10.1016/s0140-6736(21)01122-3 article EN The Lancet 2021-09-07

10.1016/j.atherosclerosis.2018.08.051 article EN Atherosclerosis 2018-09-28

Abstract Background and Aims Overweight obesity are modifiable risk factors for atherosclerotic cardiovascular disease (ASCVD) in the general population, but their prevalence individuals with heterozygous familial hypercholesterolaemia (HeFH) whether they confer additional of ASCVD independent LDL cholesterol (LDL-C) remains unclear. Methods Cross-sectional analysis was conducted 35 540 patients HeFH across 50 countries, EAS FH Studies Collaboration registry. Prevalence World Health...

10.1093/eurheartj/ehae791 article EN cc-by European Heart Journal 2025-01-13

Proteins play a crucial role in metabolism, maintaining fluid and acid-base balance antibody synthesis. Dietary proteins are important nutrients classified into: 1) animal (meat, fish, poultry, eggs dairy), and, 2) plant (legumes, nuts soy). modification is one of the most lifestyle changes that has been shown to significantly decrease risk cardiovascular (CV) disease (CVD) by attenuating related factors. The CVD burden reduced optimum diet through replacement unprocessed meat with low...

10.1016/j.clnu.2020.05.017 article EN cc-by-nc-nd Clinical Nutrition 2020-05-27

The potential for global collaborations to better inform public health policy regarding major non-communicable diseases has been successfully demonstrated by several large-scale international consortia. However, the true impact of familial hypercholesterolaemia (FH), a common genetic disorder associated with premature cardiovascular disease, is yet be reliably ascertained using similar approaches. European Atherosclerosis Society FH Studies Collaboration (EAS FHSC) new initiative...

10.1016/j.atherosclerosissup.2016.10.001 article EN cc-by-nc-nd Atherosclerosis Supplements 2016-12-01

Background Little is known about the achievement of low density lipoprotein cholesterol (LDL-C) targets in patients at cardiovascular risk receiving stable lipid-lowering therapy (LLT) countries outside Western Europe. Methods This cross-sectional observational study was conducted 452 centres (August 2015−August 2016) 18 Eastern Europe, Asia, Africa, Middle East and Latin America. Patients ( n = 9049) treated for ≥3 months with any LLT whom an LDL-C measurement on available within previous...

10.1177/2047487318777079 article EN European Journal of Preventive Cardiology 2018-05-17
Kanika Dharmayat Antonio J. Vallejo‐Vaz C. Stevens Julia Brandts Alexander R.M. Lyons and 95 more Urh Grošelj Marianne Abifadel Carlos A. Aguilar‐Salinas Khalid F. AlHabib Mutaz Al-Khnifsawi Wael Almahmeed Fahad Alnouri Rodrigo Alonso Khalid Al‐Rasadi Tester F. Ashavaid Maciej Banach Sophie Béliard Christoph J. Binder Mafalda Bourbon Krzysztof Chlebus Pablo Corral Diogo Cruz Olivier Descamps Euridiki Drogari Ronen Durst М. В. Ежов Jacques Genest Mariko Harada‐Shiba Kirsten B. Holven Steve E. Humphries Weerapan Khovidhunkit Katarina Lalić Ulrich Laufs Evangelos Liberopoulos Jeanine E. Roeters van Lennep Marcos M. Lima-Martínez Jie Lin Vincent Maher Winfried März André R. Miserez Olena Mitchenko Hapizah Nawawi Andrie G. Panayiotou György Paragh Arman Postadzhiyan Ashraf Reda Željko Reiner Ximena Reyes Fouzia Sadiq Amirhossein Sahebkar Heribert Schunkert Aleksandr B. Shek E.S.G. Stroes Ta‐Chen Su Subramaniam Tavintharan Andrey V. Susekov Alejandra Cárdenas Thanh Huong Truong Alexandros D. Tselepis Branislav Vohnout Luya Wang Shizuya Yamashita Ahmad Al‐Sarraf Nasreen Al-Sayed Kairat Davletov Bambang Dwiputra Dan Gaiţă Meral Kayıkçıoğlu Gustavs Latkovskis Adéle Marais Anne Thushara Matthias Erkin М Мirrakhimov Børge G. Nordestgaard Žaneta Petrulionienė Belma Pojskić Wilson E. Sadoh Myra Tilney Brian Tomlinson Anne Tybjærg‐Hansen Margus Viigimaa Alberico L. Catapano Tomáš Freiberger G. Kees Hovingh Pedro Mata Handrean Soran Frederick J. Raal Gerald F. Watts Laura Schreier Virginia Bañares Susanne Greber‐Platzer Margot Baumgartner-Kaut Charlotte de Gier Hans Dieplinger Florian Höllerl Reinhold Innerhofer Daniela Karall Julia Lischka Bernhard Ludvik Martin Mäser Sabine Scholl‐Bürgi

<h2>Summary</h2><h3>Background</h3> Approximately 450 000 children are born with familial hypercholesterolaemia worldwide every year, yet only 2·1% of adults were diagnosed before age 18 years via current diagnostic approaches, which derived from observations in adults. We aimed to characterise and adolescents heterozygous (HeFH) understand approaches the identification management inform future public health strategies. <h3>Methods</h3> For this cross-sectional study, we assessed younger...

10.1016/s0140-6736(23)01842-1 article EN cc-by-nc-nd The Lancet 2023-12-12

Atherosclerotic cardiovascular disease (ASCVD) and consequent acute coronary syndromes (ACS) are substantial contributors to morbidity mortality across Europe. Fortunately, as much two thirds of this disease's burden is modifiable, in particular by lipid-lowering therapy (LLT). Current guidelines based on the sound premise that, with respect low-density lipoprotein cholesterol (LDL-C), "lower better for longer", recent data have strongly emphasised need also "the earlier better". In addition...

10.1007/s40265-024-02105-5 article EN cc-by-nc Drugs 2024-11-04
Amany Elshorbagy Alexander R.M. Lyons Antonio J. Vallejo‐Vaz C. Stevens Kanika Dharmayat and 95 more Julia Brandts Alberico L. Catapano Tomáš Freiberger G. Kees Hovingh Pedro Mata Frederick J. Raal Raúl D. Santos Handrean Soran Gerald F. Watts Marianne Abifadel Carlos A. Aguilar-Salinas Khalid F. AlHabib Mutaz Al-Khnifsawi Wael Almahmeed Rodrigo Alonso Khalid Al‐Rasadi Ahmad Al‐Sarraf Tester F. Ashavaid Maciej Banach Christoph J. Binder Mafalda Bourbon Liam R. Brunham Krzysztof Chlebus Pablo Corral Diogo Cruz Kairat Davletov Olivier Descamps М. В. Ежов Dan Gaiţă Urh Grošelj Mariko Harada‐Shiba Kirsten B. Holven Meral Kayıkçıoğlu Weerapan Khovidhunkit Katarina Lalić Gustavs Latkovskis Ulrich Laufs Evangelos Liberopoulos Marcos M. Lima-Martínez Jie Lin Vincent Maher Adéle Marais Winfried März Erkin М Мirrakhimov André R. Miserez Olena Mitchenko Hapizah Nawawi Børge G. Nordestgaard Andrie G. Panayiotou György Paragh Žaneta Petrulionienė Belma Pojskić Arman Postadzhiyan Ashraf Reda Željko Reiner Ximena Reyes Fouzia Sadiq Wilson E. Sadoh Heribert Schunkert Aleksandr B. Shek Erik S.G. Stroes Ta‐Chen Su Subramaniam Tavintharan Andrey V. Susekov Myra Tilney Brian Tomlinson Thanh‐Huong Truong Alexandros D. Tselepis Anne Tybjærg‐Hansen Alejandra C. Vázquez Margus Viigimaa Branislav Vohnout Luya Wang Shizuya Yamashita Marcello Arca Maurizio Averna Laura Schreier Jing Pang Christoph Ebenbichler Hans Dieplinger Reinhold Innerhofer Yvonne Winhofer-Stöckl Susanne Greber‐Platzer Konstantin A. Krychtiuk Walter S. Speidl Hermann Toplak Kurt Widhalm Thomas M. Stulnig Kurt Huber Florian Höllerl Gersina Rega‐Kaun Lucas Kleemann Martin Mäser Sabine Scholl‐Bürgi Christoph Säly

10.1016/s2213-8587(24)00221-3 article EN cc-by-nc-nd The Lancet Diabetes & Endocrinology 2024-10-01

Despite great recent progress, familial hypercholesterolemia (FH) is still underestimated, under-diagnosed and thus undertreated worldwide. We have very little information on exact prevalence of patients with FH in the Central, Eastern Southern Europe (CESE) region. The aim study was to describe epidemiological situation CESE region from data available.All local leaders ScreenPro project were asked provide (a) expert guess (b) medical facilities focused already place (c) diagnostic criteria...

10.36290/vnl.2017.005 article EN Vnitřní lékařství 2017-01-01

Abstract Background Statin intolerance is a clinical syndrome whereby adverse effects associated with statin therapy (most commonly muscle symptoms) result in the discontinuation of therapy. increased risk cardiac outcomes. Many patients who initially experience are able to tolerate some extent. Careful stepwise diagnosis and management individuals essential enable optimal reduction cardiovascular risk. Purpose In this Position Paper International Lipid Expert Panel (ILEP), we present step...

10.1093/eurheartj/ehz747.0310 article EN European Heart Journal 2019-10-01

Familial hypercholesterolemia (FH) is a genetic disorder with well-known transmission and clinical course. Despite great recent progress, FH still underestimated, under-diagnosed thus undertreated. Furthermore it represents significant healthcare challenge as common risk factor for the premature development of coronary heart disease. The ScreenPro Project an international network project aiming at improving complex care - from timely screening, through diagnosis to up-to-date treatment...

10.36290/vnl.2017.008 article EN Vnitřní lékařství 2017-01-01

Метою даного дослідження був субаналіз поширеності та виявлення артеріальної гіпертензії (АГ) серед когорти респондентів із надлишковою масою тіла ожирінням залежно від ступеня типу ожиріння в рамках великого популяційного визначення факторів ризику, проведеного нами Україні на міській популяції у 2009–2013 рр. Визначено, що проаналізованій населення України нормальну масу мали лише 29,3 %, а 70,7 % — сумарно надлишкову I–III ступеня. Відзначалася тенденція до збільшення надлишкової маси з...

10.22141/2224-0721.3.67.2015.75265 article UK cc-by INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2016-12-28
Coming Soon ...